199 related articles for article (PubMed ID: 25993153)
1. Beyond adenocarcinoma: current treatments and future directions for squamous, small cell, and rare lung cancer histologies.
Gerber DE; Paik PK; Dowlati A
Am Soc Clin Oncol Educ Book; 2015; ():147-62. PubMed ID: 25993153
[TBL] [Abstract][Full Text] [Related]
2. Squamous cell carcinoma of the lung: molecular subtypes and therapeutic opportunities.
Perez-Moreno P; Brambilla E; Thomas R; Soria JC
Clin Cancer Res; 2012 May; 18(9):2443-51. PubMed ID: 22407829
[TBL] [Abstract][Full Text] [Related]
3. Novel therapies for advanced squamous cell carcinoma of the lung.
Koutsoukos K; Mountzios G
Future Oncol; 2016 Mar; 12(5):659-67. PubMed ID: 26880383
[TBL] [Abstract][Full Text] [Related]
4. Lung cancer histologies associated with emphysema on computed tomography.
Smith BM; Schwartzman K; Kovacina B; Taylor J; Kasymjanova G; Brandao G; Agulnik JS
Lung Cancer; 2012 Apr; 76(1):61-6. PubMed ID: 21945657
[TBL] [Abstract][Full Text] [Related]
5. Targeting the phosphatidylinositol 3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) pathway: an emerging treatment strategy for squamous cell lung carcinoma.
Beck JT; Ismail A; Tolomeo C
Cancer Treat Rev; 2014 Sep; 40(8):980-9. PubMed ID: 25037117
[TBL] [Abstract][Full Text] [Related]
6. Alternating electric fields (tumor-treating fields therapy) can improve chemotherapy treatment efficacy in non-small cell lung cancer both in vitro and in vivo.
Giladi M; Weinberg U; Schneiderman RS; Porat Y; Munster M; Voloshin T; Blatt R; Cahal S; Itzhaki A; Onn A; Kirson ED; Palti Y
Semin Oncol; 2014 Oct; 41 Suppl 6():S35-41. PubMed ID: 25213867
[TBL] [Abstract][Full Text] [Related]
7. Targeting FGFR in Squamous Cell Carcinoma of the Lung.
Hashemi-Sadraei N; Hanna N
Target Oncol; 2017 Dec; 12(6):741-755. PubMed ID: 28685321
[TBL] [Abstract][Full Text] [Related]
8. The utility of fine-needle aspiration in the diagnosis of primary and metastatic tumors to the lung: a retrospective examination of 1,032 cases.
Adams J; Wu HH
Acta Cytol; 2012; 56(6):590-5. PubMed ID: 23207436
[TBL] [Abstract][Full Text] [Related]
9. [Surgical treatment for the second double lung cancers following chemotherapy for small cell lung cancer].
Momozane T; Higashiyama M; Maeda J; Okami J; Oda K; Imamura F; Yoneda K; Takenaka A; Kodama K
Kyobu Geka; 2009 Feb; 62(2):117-21. PubMed ID: 19202930
[TBL] [Abstract][Full Text] [Related]
10. [Roles and applications of liquid-based cytology in sputum samples from lung cancer patients].
Cai L; Chen LZ; Chen Q; Wu LP; He LX; Zheng J
Zhonghua Bing Li Xue Za Zhi; 2009 Dec; 38(12):834-5. PubMed ID: 20193461
[No Abstract] [Full Text] [Related]
11. Japanese Lung Cancer Registry Study: first prospective enrollment of a large number of surgical and nonsurgical cases in 2002.
Sawabata N; Asamura H; Goya T; Mori M; Nakanishi Y; Eguchi K; Koshiishi Y; Okumura M; Miyaoka E; Fujii Y;
J Thorac Oncol; 2010 Sep; 5(9):1369-75. PubMed ID: 20683209
[TBL] [Abstract][Full Text] [Related]
12. Algorithm for the treatment of advanced or metastatic squamous non-small-cell lung cancer: an evidence-based overview.
Daaboul N; Nicholas G; Laurie SA
Curr Oncol; 2018 Jun; 25(Suppl 1):S77-S85. PubMed ID: 29910650
[TBL] [Abstract][Full Text] [Related]
13. Approach to the diagnosis of neuroendocrine lung neoplasms: variabilities and pitfalls.
Hammar SP
Semin Thorac Cardiovasc Surg; 2006; 18(3):183-90. PubMed ID: 17185177
[TBL] [Abstract][Full Text] [Related]
14. Aldehyde dehyderogenase (ALDH1A1) delineating the normal and cancer stem cells in spectral lung lesions: An immunohistochemical appraisal.
Yassin Fel-Z
Pathol Res Pract; 2016 May; 212(5):398-409. PubMed ID: 26907783
[TBL] [Abstract][Full Text] [Related]
15. FGFR1/3 tyrosine kinase fusions define a unique molecular subtype of non-small cell lung cancer.
Wang R; Wang L; Li Y; Hu H; Shen L; Shen X; Pan Y; Ye T; Zhang Y; Luo X; Zhang Y; Pan B; Li B; Li H; Zhang J; Pao W; Ji H; Sun Y; Chen H
Clin Cancer Res; 2014 Aug; 20(15):4107-14. PubMed ID: 24850843
[TBL] [Abstract][Full Text] [Related]
16. Desmoglein-3 and Napsin A double stain, a useful immunohistochemical marker for differentiation of lung squamous cell carcinoma and adenocarcinoma from other subtypes.
Agackiran Y; Ozcan A; Akyurek N; Memis L; Findik G; Kaya S
Appl Immunohistochem Mol Morphol; 2012 Jul; 20(4):350-5. PubMed ID: 22495379
[TBL] [Abstract][Full Text] [Related]
17. Genetic alterations defining NSCLC subtypes and their therapeutic implications.
Pikor LA; Ramnarine VR; Lam S; Lam WL
Lung Cancer; 2013 Nov; 82(2):179-89. PubMed ID: 24011633
[TBL] [Abstract][Full Text] [Related]
18. Non-small cell carcinoma of the lung.
Golomb HM
Semin Oncol; 1983 Mar; 10(1):1-122. PubMed ID: 6301061
[No Abstract] [Full Text] [Related]
19. Evaluation of role of Notch3 signaling pathway in human lung cancer cells.
Hassan WA; Yoshida R; Kudoh S; Motooka Y; Ito T
J Cancer Res Clin Oncol; 2016 May; 142(5):981-93. PubMed ID: 26838758
[TBL] [Abstract][Full Text] [Related]
20. High rate of FGFR1 amplifications in brain metastases of squamous and non-squamous lung cancer.
Preusser M; Berghoff AS; Berger W; Ilhan-Mutlu A; Dinhof C; Widhalm G; Dieckmann K; Wöhrer A; Hackl M; von Deimling A; Streubel B; Birner P
Lung Cancer; 2014 Jan; 83(1):83-9. PubMed ID: 24183471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
